1742-1743 / 2437
Phase 0 Trial of AZD1775 in
Patients with First-Recurrence
Glioblastoma
Nader Sanai, Jing Li, Julie Boerner, Harshil Dhruv, Michael Berens,
and Patricia LoRusso
Barrow Neurological Institute, AZ; Translational Genomic Research Institute (TGen),
AZ; Karmanos Cancer Institute, MI; Yale University Cancer Center, CT